QQ客服 官方微博 反馈留言

	Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization
	Yang, Zongguo; Zhang, Jianliang; Lu, Yunfei; Xu, Qingnian; Tang, Bozong; Wang, Qiang; Zhang, Wensi; Chen, Shishi; Lu, Lingqing; Chen, Xiaorong
刊名	ONCOTARGET
	2015
卷号	6期号:40
关键词	lymphocyte cell aspartate aminotransferase-lymphocyte ratio index systemic immune-inflammation index survival hepatocellular carcinoma
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4643448
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Yang, Zongguo,Zhang, Jianliang,Lu, Yunfei,et al. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization[J]. ONCOTARGET,2015,6(40).
APA	Yang, Zongguo.,Zhang, Jianliang.,Lu, Yunfei.,Xu, Qingnian.,Tang, Bozong.,...&Chen, Xiaorong.(2015).Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.ONCOTARGET,6(40).
MLA	Yang, Zongguo,et al."Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization".ONCOTARGET 6.40(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。